"Quite honestly, I don't even know anything about MSNBC," Bachmann said. "It's not a network that I watch and most of the American people agree with that assessment. They aren't watching it either. And that's why Fox's ratings - I mean it's like CNN, CNBC, MSNBC combined. I think Fox even exceeded one of the major networks last week. They're on the ascendency."
Twin Cities news consumers aren't well served, and it may get worse.
Avista Capital Partners, which owns the Minneapolis Star Tribune, said earlier this month that its investment in the Strib is performing so poorly that it had to be written down by 75%. Earlier, the New York Post reported the possibility that the paper might go bankrupt. That possibility will loom as long as the Strib, which many locals refer to as "Red Star Tribune," largely serves as the apparent PR outlet of the Democratic Farm Labor Party (the Gopher State's Democrats).
If a Strib bankruptcy were to occur, and it ceases publication, the St. Paul Pioneer Press is less than ready to step into the breach, at least if Tom Webb's article Thursday about recent food price inflation is any indication.
What's up at the supermarket? Prices for almost everything
Food inflation hit an 18-year high in April, with grocery prices rising 1.5 percent for the month, the government said Wednesday. Prices rose in every aisle - dairy, breads, meats, beverages, fruits and vegetables. It means $53 more a month to feed a family of four with a typical food budget.
What a difference a headline makes. An alert tipster in Minnesota sent the Media Research Center a clip from the August 10 St. Paul Pioneer Press, which included this scary-sounding headline over a story about a Food and Drug Administration report: “Heartburn Drugs Subject of Federal Safety Inquiry.”
The story, distributed by the Los Angeles Times News Service, was about whether two commonly prescribed drugs, Nexium and Prilosec, might cause heart problems. Maybe, suggested writer Ricardo Alonso-Zaldivar: “Federal regulators Thursday said they have opened a safety investigation of two popular heartburn drugs — Nexium, marketed as the ‘purple pill,’ and Prilosec, its older chemical cousin — after receiving clinical data that appeared to link them to serious heart problems.”